In this Section |
272947 National, Federal, Community, Faith-based and Corporate partners taking action to close the gap in adult influenza vaccinationThursday, June 28, 2012
: 9:10 AM - 9:30 AM
Influenza vaccination rates remain low for the Adult population. During the 2010-2011 Influenza season, only 32.3% of Hispanics and 34.2% of Black or African American adults compared to 43.2% for general white population had received an Influenza vaccination. This disparity in the rate of vaccination has continued for some time despite targeted vaccine improvement efforts. To reduce this disparity, the U.S Department of Health and Human Services Office of Minority Health established a partnership during the 2011-2012 flu season with a national pharmacy chain and State, local, faith, and community partners to launch a new collaborative effort to improve vaccination rates in these targeted groups. This presentation will describe the goals, strategies, accomplishments, challenges, and outcomes achieved through this partnership, and identify opportunities for future collaboration with similarly interested organizations.
Learning Areas:
Communication and informaticsEpidemiology Implementation of health education strategies, interventions and programs Protection of the public in relation to communicable diseases including prevention or control Public health or related education Public health or related organizational policy, standards, or other guidelines Learning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the Associate Director for Research and Policy in the Department of HHS, OMH. I advise the Director and Deputy Assistant Secretary for Minority Health on wide-ranging health and healthcare disparities priorities. My public health career spans over 28 years, sixteen in government including 13 years at the Centers for Disease Control and Prevention. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3000.0: Developing unique and emerging partnerships
|